Skip to content

Phase II trial to evaluate the safety, feasibility and efficacy of using therapeutic weighted blankets for agitation in patients with dementia in acute care settings.

Phase II trial to evaluate the safety, feasibility and efficacy of using therapeutic weighted blankets for agitation in patients with dementia in acute care settings.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12623000003673
Enrollment
60
Registered
2023-01-09
Start date
2023-05-10
Completion date
2024-01-09
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The rate of hospitalisations for persons living with dementia has increased in recent years, and the average length of stay is 13 days (five times the average hospitalisation) (AIHW, 2021). Persons with dementia can often experience behavioural and psychological symptoms of dementia (BPSD) including agitation while in hospital. Agitation experienced by patients with dementia is associated with poor health outcomes, long-term hospitalisation, overuse of medication, and increased health care costs (Cerejeira et al, 2012). Medical-grade therapeutic weighted blankets may be safe, and feasible to reduce agitation experienced by patients with dementia during hospitalisation. This research aims to evaluate the feasibility, safety and efficacy of using therapeutic weighted blankets to reduce agitation in patients with dementia in acute care settings. Objectives: To report the safety of using weighted blankets for patients who have a dementia diagnosis in acute healthcare settings. To report the feasibility of using weighted blankets for patients who have a dementia diagnosis in acute healthcare settings. To report the efficacy of using weighted blankets for patients who have a dementia diagnosis in acute healthcare settings.

Interventions

Use of a therapeutic weighted blanket for patients with a diagnosis of dementia, who have experienced agitation in acute care. Upon settling acute care patients who have dementia and have experienced agitation during their hospitalisation for the evening (and in conjunction with the nurse caring for the patient), the research assistant will apply an appropriately weighted blanket based on the patient’s weight (less than 10% of the patient’s body weight) on patients randomised to the interventio

Use of a therapeutic weighted blanket for patients with a diagnosis of dementia, who have experienced agitation in acute care. Upon settling acute care patients who have dementia and have experienced agitation during their hospitalisation for the evening (and in conjunction with the nurse caring for the patient), the research assistant will apply an appropriately weighted blanket based on the patient’s weight (less than 10% of the patient’s body weight) on patients randomised to the intervention arm. Each participant will only receive the intervention once and the research assistant will supervise the participant for the duration of blanket use. The blankets to be used in the trial will weigh 5.5kg, 6.6kg or 7.7kgs. Where a blanket is greater than 10% of a patient’s body weight the patient shall be deemed ineligible for the intervention group. Weighted blankets will be able to be removed by individuals should they wish, this will be documented as the study endpoint, and the time applied/ tolerated will be recorded. There are no standardised guidelines for the safe use of weighted blankets by people in hospital settings. Parameters have been adapted from Harris and Titler (2022) whose study tested safety and effectiveness in people with dementia in the home environment and they did not report any adverse events. The blanket will be placed no higher than the patient’s shoulder tip and not below the ankles. Blankets will be placed for a period of no longer than 60 minutes, or until such time as the patient removes the blanket themselves.

Sponsors

Queensland University of Technology
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used) (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient participants will be deemed eligible for inclusion based on the following criteria: a) A diagnosis of dementia by a physician and noted in their medical record b) admitted to the study unit c) identified and assessed by health care staff using the PAS as being agitated during their stay (score greater than 0) Staff participants will be deemed eligible for inclusion in the study based on the following criteria: a) They have been the primary nurse caring for a patient who has participated in the study

Exclusion criteria

The following patient participants will be excluded from the study a) Those being nursed on an end-of-life pathway b) Those assessed as clinically deteriorating (identified using the Adult Deterioration Detections System as scoring greater than 3) c) Patients diagnosed with one of the following • obstructive sleep apnoea • Claustrophobia d) Unable to speak or understand English

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026